We are live on ! Find out more
AMED

Amedisys
AMED

Delisted

AMED was delisted on the 14th of August, 2025.

Back to rankings

288 hedge funds and large institutions have $2.85B invested in Amedisys in 2024 Q2 according to their latest regulatory filings, with 42 funds opening new positions, 93 increasing their positions, 104 reducing their positions, and 32 closing their positions.

New
Increased
Maintained
Reduced
Closed

31% more first-time investments, than exits

New positions opened: 42 | Existing positions closed: 32

18% more funds holding in top 10

Funds holding in top 10: 11 → 13 (+2)

2% more funds holding

Funds holding: 283 → 288 (+5)

0.07% more ownership

Funds ownership: 94.92% → 94.99% (+0.07%)

0% less capital invested

Capital invested by funds: $2.86B → $2.85B (-$5.8M)

11% less repeat investments, than reductions

Existing positions increased: 93 | Existing positions reduced: 104

82% less call options, than puts

Call options by funds: $17.1M | Put options by funds: $94.3M

Holders
288
Holders Change
+5
Holders Change %
+1.77%
% of All Funds
4.16%
Holding in Top 10
13
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+18.18%
% of All Funds
0.19%
New
42
Increased
93
Reduced
104
Closed
32
Calls
$17.1M
Puts
$94.3M
Net Calls
-$77.2M
Net Calls Change
-$8.21M

Top Buyers

1
Goldman Sachs
Goldman Sachs
New York
+$96.9M
2
FCM
Farallon Capital Management
California
+$27.9M
3
AllianceBernstein
AllianceBernstein
Tennessee
+$19.4M
4
LP
LMR Partners
United Kingdom
+$18.5M
5
SGCM
Sand Grove Capital Management
United Kingdom
+$17.5M

Top Sellers

1
Millennium Management
Millennium Management
New York
-$32.3M
2
PWAM
Park West Asset Management
California
-$29.6M
3
WP
Woodline Partners
California
-$19.5M
4
MAM
Melqart Asset Management
United Kingdom
-$18.9M
5
Boston Partners
Boston Partners
Massachusetts
-$18.3M
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$296M +$11.8M +126,922 +4%
BlackRock
2
BlackRock
New York
$285M +$8.74M +94,159 +3%
FCM
3
Farallon Capital Management
California
$120M +$27.9M +300,200 +30%
AAM
4
Alpine Associates Management
Florida
$118M +$1.02M +11,000 +0.9%
Fidelity International
5
Fidelity International
Bermuda
$105M -$15M -161,630 -12%
Goldman Sachs
6
Goldman Sachs
New York
$102M +$96.9M +1,043,958 +1,634%
WCMNY
7
Westchester Capital Management (New York)
New York
$93.8M +$3.74M +40,269 +4%
State Street
8
State Street
Massachusetts
$88.8M +$398K +4,284 +0.4%
Millennium Management
9
Millennium Management
New York
$78.8M -$32.3M -348,036 -29%
PCM
10
Pentwater Capital Management
Florida
$71.7M +$13.1M +141,259 +22%
AllianceBernstein
11
AllianceBernstein
Tennessee
$71.3M +$19.4M +209,422 +37%
Mackenzie Financial
12
Mackenzie Financial
Ontario, Canada
$68.4M -$1.11M -11,968 -2%
WIC
13
Water Island Capital
New York
$64.4M -$170K -1,837 -0.3%
MF
14
Magnetar Financial
Illinois
$56.5M -$317K -3,416 -0.6%
Geode Capital Management
15
Geode Capital Management
Massachusetts
$51.4M +$924K +9,960 +2%
Dimensional Fund Advisors
16
Dimensional Fund Advisors
Texas
$47.2M +$1.82M +19,660 +4%
CAM
17
Cresset Asset Management
Illinois
$41.8M +$108K +1,167 +0.3%
SGCM
18
Sand Grove Capital Management
United Kingdom
$39.9M +$17.5M +188,475 +76%
Qube Research & Technologies (QRT)
19
Qube Research & Technologies (QRT)
United Kingdom
$37.8M -$1.89M -20,318 -5%
AA
20
AQR Arbitrage
Connecticut
$36.8M -$4.02M -43,299 -10%
Calamos Advisors
21
Calamos Advisors
Illinois
$36.5M +$3.82M +41,220 +12%
Norges Bank
22
Norges Bank
Norway
$35.7M +$966K +10,416 +3%
LP
23
LMR Partners
United Kingdom
$35.4M +$18.5M +199,367 +107%
Bank of America
24
Bank of America
North Carolina
$34.3M -$1.79M -19,334 -5%
MAM
25
Melqart Asset Management
United Kingdom
$32.3M -$18.9M -204,123 -37%
1
2 3 4 5

AMED Hedge Fund Activity: Q2 2024 in Review

288 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Amedisys (AMED) for Q2 2024, worth a combined $2.85B — down 0.2% from $2.86B a quarter earlier.

Buyers outnumbered sellers: 42 funds opened new AMED positions and 32 closed out — a net gain of 10 holders — while 93 added to existing stakes and 104 trimmed.

The largest buyer was Goldman Sachs, adding an estimated $96.9M. The largest seller was Millennium Management, cutting an estimated $32.3M.

  • 288 institutional investors held Amedisys (AMED) as of Q2 2024, up from 283 in Q1 2024.
  • Funds reported $2.85B of Amedisys stock for Q2 2024, down 0.2% quarter-over-quarter.
  • 42 funds opened new Amedisys positions in Q2 2024 and 32 closed out, a net change of +10 holders.
  • The largest Amedisys buyer in Q2 2024 was Goldman Sachs, an estimated $96.9M added.
  • The largest Amedisys seller in Q2 2024 was Millennium Management, an estimated $32.3M sold.

Based on aggregated 13F filings for Q2 2024.